Denkert C - Search Results

1

Tissue-Based Metabolomics to Analyze the Breast Cancer Metabolome.

Budczies J, Denkert C. Budczies J, et al. Among authors: denkert c. Recent Results Cancer Res. 2016;207:157-75. doi: 10.1007/978-3-319-42118-6_7. Recent Results Cancer Res. 2016. PMID: 27557538 Review.

2

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.

Denkert C, Winzer KJ, Müller BM, Weichert W, Pest S, Köbel M, Kristiansen G, Reles A, Siegert A, Guski H, Hauptmann S. Denkert C, et al. Cancer. 2003 Jun 15;97(12):2978-87. doi: 10.1002/cncr.11437. Cancer. 2003. PMID: 12784332 Free article.

3

Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status.

Fritzsche F, Gansukh T, Borgoño CA, Burkhardt M, Pahl S, Mayordomo E, Winzer KJ, Weichert W, Denkert C, Jung K, Stephan C, Dietel M, Diamandis EP, Dahl E, Kristiansen G. Fritzsche F, et al. Among authors: denkert c. Br J Cancer. 2006 Feb 27;94(4):540-7. doi: 10.1038/sj.bjc.6602956. Br J Cancer. 2006. PMID: 16434994 Free PMC article.

4

Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer.

Burkhardt M, Mayordomo E, Winzer KJ, Fritzsche F, Gansukh T, Pahl S, Weichert W, Denkert C, Guski H, Dietel M, Kristiansen G. Burkhardt M, et al. Among authors: denkert c. J Clin Pathol. 2006 Apr;59(4):403-9. doi: 10.1136/jcp.2005.028209. Epub 2006 Feb 16. J Clin Pathol. 2006. PMID: 16484444 Free PMC article.

5

Prognostic relevance of AGR2 expression in breast cancer.

Fritzsche FR, Dahl E, Pahl S, Burkhardt M, Luo J, Mayordomo E, Gansukh T, Dankof A, Knuechel R, Denkert C, Winzer KJ, Dietel M, Kristiansen G. Fritzsche FR, et al. Among authors: denkert c. Clin Cancer Res. 2006 Mar 15;12(6):1728-34. doi: 10.1158/1078-0432.CCR-05-2057. Clin Cancer Res. 2006. PMID: 16551856 Free article.

6

Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors.

Denkert C, Budczies J, Kind T, Weichert W, Tablack P, Sehouli J, Niesporek S, Könsgen D, Dietel M, Fiehn O. Denkert C, et al. Cancer Res. 2006 Nov 15;66(22):10795-804. doi: 10.1158/0008-5472.CAN-06-0755. Cancer Res. 2006. PMID: 17108116

7

Resistance to chemotherapy in ovarian carcinoma.

Lage H, Denkert C. Lage H, et al. Among authors: denkert c. Recent Results Cancer Res. 2007;176:51-60. doi: 10.1007/978-3-540-46091-6_6. Recent Results Cancer Res. 2007. PMID: 17607916 Review.

8

Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover.

Denkert C, Budczies J, Weichert W, Wohlgemuth G, Scholz M, Kind T, Niesporek S, Noske A, Buckendahl A, Dietel M, Fiehn O. Denkert C, et al. Mol Cancer. 2008 Sep 18;7:72. doi: 10.1186/1476-4598-7-72. Mol Cancer. 2008. PMID: 18799019 Free PMC article.

9

[Molecular profiling and predictive signatures. Biomarker analysis in ovarian cancer].

Denkert C. Denkert C. Pathologe. 2008 Nov;29 Suppl 2:168-71. doi: 10.1007/s00292-008-1073-4. Pathologe. 2008. PMID: 18931999 Review. German.

10

Phospho-mTOR and phospho-4EBP1 in endometrial adenocarcinoma: association with stage and grade in vivo and link with response to rapamycin treatment in vitro.

Darb-Esfahani S, Faggad A, Noske A, Weichert W, Buckendahl AC, Müller B, Budczies J, Röske A, Dietel M, Denkert C. Darb-Esfahani S, et al. Among authors: denkert c. J Cancer Res Clin Oncol. 2009 Jul;135(7):933-41. doi: 10.1007/s00432-008-0529-5. Epub 2008 Dec 24. J Cancer Res Clin Oncol. 2009. PMID: 19107520

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

477 results

Search Page